Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial

Published:2023-11 Issue: Volume: Page:113459
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Topkan Erkan^ORCID,Somay Efsun,Selek Ugur^ORCID,Pehlivan Berrin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference10 articles.

1. Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: a single-arm, phase 2 trial;Guo;Eur J Cancer,2023

2. Systematic review of dose--volume correlates for structures related to late swallowing disturbances after radiotherapy for head and neck cancer;Duprez;Dysphagia,2013

3. Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1);Inada;Radiat Oncol,2022

4. Evaluation of the risk of grade 3 oral and pharyngeal dysphagia using atlas-based method and multivariate analyses of individual patient dose distributions;Otter;Int J Radiat Oncol Biol Phys,2015

5. Assessment of the impact of osteoradionecrosis on quality-of-life measures in patients with head and neck cancer;Somay,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP